The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside

Krysztof W. Pankiewicz, Kyoichi A. Watanabe, Krystyna Lesiak-Watanabe, Barry M. Goldstein, Hiremagalur N. Jayaram

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Oncolytic C-nucleosides, tiazofurin (2-β-D-ribofuranosylthiazole-4-carboxamide) and benzamide riboside (3-β-D-ribofuranosylbenzamide) are converted in cell into active metabolites thiazole-4-carboxamide- and benzamide adenine dinucleotide, TAD and BAD, respectively. TAD and BAD as NAD analogues were found to bind at the nicotinamide adenine dinucleotide (cofactor NAD) site of inosine monophosphate dehydrogenase (IMPDH), an important target in cancer treatment. The synthesis and evaluation of anticancer activity of a number of C-nucleosides related to tiazofurin and nicotinamide riboside then followed and are reviewed herein. Interestingly, pyridine C-nucleosides (such as C-nicotinamide riboside) are not metabolized into the corresponding NAD analogues in cell. Their conversion by chemical methods is described. As dinucleotides these compounds show inhibition of IMPDH in low micromolar level. Also, the synthesis of BAD in metabolically stable bis(phosphonate) form is discussed indicating the usefulness of such preformed inhibitors in drug development. Among tiazofurin analogues, Franchetti and Grifantini found, that the replacement of the sulfur by oxygen (as in oxazafurin) but not the removal of nitrogen (tiophenfurin) of the thiazole ring resulted in inactive compounds. The anti cancer activity of their synthetic dinucleotide analogues indicate that inactive compounds are not only poorly metabolized in cell but also are weak inhibitors of IMPDH as dinucleotides.

Original languageEnglish (US)
Pages (from-to)733-741
Number of pages9
JournalCurrent Medicinal Chemistry
Volume9
Issue number7
StatePublished - 2002
Externally publishedYes

Fingerprint

tiazofurin
Niacinamide
Nucleosides
Inosine Monophosphate
NAD
Thiazoles
Oxidoreductases
Organophosphonates
Oncology
Adenine
Metabolites
Sulfur
Neoplasms
Nitrogen
Oxygen
Pharmaceutical Preparations

Keywords

  • Benzamide riboside
  • C-nucleosides
  • Chemistry of NAD analogues
  • NAD

ASJC Scopus subject areas

  • Organic Chemistry
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Pharmacology

Cite this

Pankiewicz, K. W., Watanabe, K. A., Lesiak-Watanabe, K., Goldstein, B. M., & Jayaram, H. N. (2002). The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside. Current Medicinal Chemistry, 9(7), 733-741.

The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside. / Pankiewicz, Krysztof W.; Watanabe, Kyoichi A.; Lesiak-Watanabe, Krystyna; Goldstein, Barry M.; Jayaram, Hiremagalur N.

In: Current Medicinal Chemistry, Vol. 9, No. 7, 2002, p. 733-741.

Research output: Contribution to journalArticle

Pankiewicz, KW, Watanabe, KA, Lesiak-Watanabe, K, Goldstein, BM & Jayaram, HN 2002, 'The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside', Current Medicinal Chemistry, vol. 9, no. 7, pp. 733-741.
Pankiewicz, Krysztof W. ; Watanabe, Kyoichi A. ; Lesiak-Watanabe, Krystyna ; Goldstein, Barry M. ; Jayaram, Hiremagalur N. / The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside. In: Current Medicinal Chemistry. 2002 ; Vol. 9, No. 7. pp. 733-741.
@article{9bb6bfc3a78144798083ad12c237b146,
title = "The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside",
abstract = "Oncolytic C-nucleosides, tiazofurin (2-β-D-ribofuranosylthiazole-4-carboxamide) and benzamide riboside (3-β-D-ribofuranosylbenzamide) are converted in cell into active metabolites thiazole-4-carboxamide- and benzamide adenine dinucleotide, TAD and BAD, respectively. TAD and BAD as NAD analogues were found to bind at the nicotinamide adenine dinucleotide (cofactor NAD) site of inosine monophosphate dehydrogenase (IMPDH), an important target in cancer treatment. The synthesis and evaluation of anticancer activity of a number of C-nucleosides related to tiazofurin and nicotinamide riboside then followed and are reviewed herein. Interestingly, pyridine C-nucleosides (such as C-nicotinamide riboside) are not metabolized into the corresponding NAD analogues in cell. Their conversion by chemical methods is described. As dinucleotides these compounds show inhibition of IMPDH in low micromolar level. Also, the synthesis of BAD in metabolically stable bis(phosphonate) form is discussed indicating the usefulness of such preformed inhibitors in drug development. Among tiazofurin analogues, Franchetti and Grifantini found, that the replacement of the sulfur by oxygen (as in oxazafurin) but not the removal of nitrogen (tiophenfurin) of the thiazole ring resulted in inactive compounds. The anti cancer activity of their synthetic dinucleotide analogues indicate that inactive compounds are not only poorly metabolized in cell but also are weak inhibitors of IMPDH as dinucleotides.",
keywords = "Benzamide riboside, C-nucleosides, Chemistry of NAD analogues, NAD",
author = "Pankiewicz, {Krysztof W.} and Watanabe, {Kyoichi A.} and Krystyna Lesiak-Watanabe and Goldstein, {Barry M.} and Jayaram, {Hiremagalur N.}",
year = "2002",
language = "English (US)",
volume = "9",
pages = "733--741",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "7",

}

TY - JOUR

T1 - The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside

AU - Pankiewicz, Krysztof W.

AU - Watanabe, Kyoichi A.

AU - Lesiak-Watanabe, Krystyna

AU - Goldstein, Barry M.

AU - Jayaram, Hiremagalur N.

PY - 2002

Y1 - 2002

N2 - Oncolytic C-nucleosides, tiazofurin (2-β-D-ribofuranosylthiazole-4-carboxamide) and benzamide riboside (3-β-D-ribofuranosylbenzamide) are converted in cell into active metabolites thiazole-4-carboxamide- and benzamide adenine dinucleotide, TAD and BAD, respectively. TAD and BAD as NAD analogues were found to bind at the nicotinamide adenine dinucleotide (cofactor NAD) site of inosine monophosphate dehydrogenase (IMPDH), an important target in cancer treatment. The synthesis and evaluation of anticancer activity of a number of C-nucleosides related to tiazofurin and nicotinamide riboside then followed and are reviewed herein. Interestingly, pyridine C-nucleosides (such as C-nicotinamide riboside) are not metabolized into the corresponding NAD analogues in cell. Their conversion by chemical methods is described. As dinucleotides these compounds show inhibition of IMPDH in low micromolar level. Also, the synthesis of BAD in metabolically stable bis(phosphonate) form is discussed indicating the usefulness of such preformed inhibitors in drug development. Among tiazofurin analogues, Franchetti and Grifantini found, that the replacement of the sulfur by oxygen (as in oxazafurin) but not the removal of nitrogen (tiophenfurin) of the thiazole ring resulted in inactive compounds. The anti cancer activity of their synthetic dinucleotide analogues indicate that inactive compounds are not only poorly metabolized in cell but also are weak inhibitors of IMPDH as dinucleotides.

AB - Oncolytic C-nucleosides, tiazofurin (2-β-D-ribofuranosylthiazole-4-carboxamide) and benzamide riboside (3-β-D-ribofuranosylbenzamide) are converted in cell into active metabolites thiazole-4-carboxamide- and benzamide adenine dinucleotide, TAD and BAD, respectively. TAD and BAD as NAD analogues were found to bind at the nicotinamide adenine dinucleotide (cofactor NAD) site of inosine monophosphate dehydrogenase (IMPDH), an important target in cancer treatment. The synthesis and evaluation of anticancer activity of a number of C-nucleosides related to tiazofurin and nicotinamide riboside then followed and are reviewed herein. Interestingly, pyridine C-nucleosides (such as C-nicotinamide riboside) are not metabolized into the corresponding NAD analogues in cell. Their conversion by chemical methods is described. As dinucleotides these compounds show inhibition of IMPDH in low micromolar level. Also, the synthesis of BAD in metabolically stable bis(phosphonate) form is discussed indicating the usefulness of such preformed inhibitors in drug development. Among tiazofurin analogues, Franchetti and Grifantini found, that the replacement of the sulfur by oxygen (as in oxazafurin) but not the removal of nitrogen (tiophenfurin) of the thiazole ring resulted in inactive compounds. The anti cancer activity of their synthetic dinucleotide analogues indicate that inactive compounds are not only poorly metabolized in cell but also are weak inhibitors of IMPDH as dinucleotides.

KW - Benzamide riboside

KW - C-nucleosides

KW - Chemistry of NAD analogues

KW - NAD

UR - http://www.scopus.com/inward/record.url?scp=0036244516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036244516&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 733

EP - 741

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 7

ER -